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Although investigations to date have demonstrated the ability of the 
nionocyte/macropliage to synthesize complement components. only a limited 
number of studies on complement synthesis by nonhepatic tissue cells have been 
reported. To begin to  fill this gap in our knowledge we have recently evaluated the 
ability of lung tissue cells to synthesize and secrete various complement 
components in vitro. Using 35.5-methionine incorporation and immunoprecipitation 
techniques we have previously demonstrated the ability human lung type I1 
pneumocytes (A549) and human lung fibroblasts (WI-38), to synthesize and secrete 
a variety of both early and terminal complement components. as well as several 
regulatory proteins including Clr, CIS, C4. C3, C5, C6, C7, C8, C9, Factor B, 
Factor H, Factor I and Cls inactivator. Our present studies demonstrate the 
capability of silica to regulate complement component production by A549 cells, but 
not complement component production by WI-38 cells. Specifically, using 
sensitive ELISAs we demonstrated that a non-toxic dose of silica had the capability 
to suppress the production of both C3 and C5 by A549 pneumocytes by 40-50 
percent. but had no effect on C3 or C5 synthesis by WI-38 fibroblasts. 
Add i t  i o n a1 1 y , us i n g 3 S - met h i o n in e in  c o rpor a t i o n and T C A p re c i p i t at i 0 n 
techniques, we demonstrated that suppression of C 3  and C5 production by silica 
treated A549 pneumocytes was not a result of suppression of' total protein 
hynthesis. These studies demonstrate that silica. which has been implicated in 
pulmonary diseases, has the capability to regulate local complement production by 
lung tissue cells irr ritro. Itz 1i i .o.  t h i b  xuppression of complement production by 
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526 ROTHMAN ET AL. 
the type I1 pneumocytes could alter the local tissue reservoir of complement 
components during infection and pulmonary injury, thus resulting in depressed 
pulmonary host defense. 
INTRODUCTION 
Our understanding of the importance of the complement system in host 
defense and inflammation has grown significantly from the original observations 
over a century ago that serum contained heat liable proteins which were 
bactericidal(l). Today, the complement system is seen as a complex cascade of 
biochemical reactions which not only play a central role in host defense and 
inflammation, but have been implicated as regulatory molecules in immune 
responses as well as the coagulation pathway (2). Previously, control of the tissue 
levels of individual complement components was generally believed to be a result of 
nonspecific diffusion associated with changes in vasopermeability. Thus, tissue 
complement concentrations were thought to be only a reflection of the humoral 
complement levels. More recently, questions have been raised about the existence 
and significance of local synthesis and secretion of complement components on the 
regulation of host defense and inflammation within tissues. Generally, the 
investigations into the question of cellular synthesis and secretion of complement 
components have focussed on the monocyte/macrophage. These investigations 
have demonstrated that the monocyte/macrophage has the capability to synthesize 
many complement components and regulatory proteins, including C1, C4, C2,  C3, 
C5, Factor B, Factor D, Factor H, Factor I, properdin and C1 inhibitor (3,4,5). 
Recent studies have reported that a variety of factors or agents can regulate 
complement production by the monocyte/macrophage in v i m .  These agents 
include antigen sensitized sheep red blood cells, immune complexes, 
lipopolysaccharide and interferon-gamma (5,7,8,9). Although these studies have 
provided important insights into the potential contribution of recruited cells to local 
concentrations of complement components and regulatory proteins, very little is 
known about the contribution of resident or tissue cells to local complement levels. 
To begin to fill this important gap area. our laboratory has recently demonstrated the 
ability of prototypic lung cells, i.e. human type I1 pneumocytes (A549) and human 
lung fibroblasts (WI-38), to synthesize and secrete a variety of complement 



















































SILICA COMPLEMENT SUPPRESSION 527 
present studies we demonstrated the ability of silica to suppress complement 
component production by type I1 pneumocytes, but not WI-38 fibroblasts. 
Specifically, these studies demonstrated that although silica particles suppressed C3 
and C5 protein production by A549 pneumocytes, silica had no effect on A549 cell 
viability or total protein synthesis by these cells, suggesting that suppression of 
both C3 and C5 production was a specific response rather than a generalized 
response of the type I1 pneumocytes to silica. Interestingly, the C3 and C5 levels 
produced by A549 pneumocytes cultured under optimal conditions, i.e. in the 
presence of FBS and absence of silica particles, were significantly higher than the 
C3 and C5 levels produced by A549 cells cultured in 1)  the presence of FBS and 
silica. or 2 )  cells cultured in serum free conditions in the presence or absence of 
silica. These results suggest that complement production by A549 pneumocytes is 
responsive to not only silica, but also to culture conditions. i.e., influence of serum 
factors and/or nutrients. Thus, these data demonstrate that silica can suppress 
production of at least the third and fifth complement components by type I1 
pneumocytes in LJitro, and in iivo this suppression may have a major impact on not 
only host defense but also on the course of pulmonary inflammation by lowering 
tissue complement levels. 
METHODS 
AS49 and WI-38 Cell Cultures 
Passage 76 human lung type I1 pneumocyte cell line (A539. ATCC CCL 
185). and passage 13 human lung fibroblast cell line (WI-38, ATCC CCL 75) were 
purchased from American Type Culture Collection (Rockville, MD). The A549 cell 
line was maintained in F12 Ham's medium (Kansas City Biological, Kansas City, 
MO) and the WI-38 cell line was maintained in Eagle's minimum essential medium 
(MEM) (Kansas City Biological, Kansas City, MO). Both types of media were 
supplemented with 15% fetal bovine serum (FBS) (Sterile Systems. Inc.. Logan, 
UT), 20 pglml gentamicin, 0.5 pglrnl amphotericin B, 0.1 mM nonessential amino 
acids. 4 mM glutamine, and 1 m1/100 ml medium of MEM vitamins (1OOX) 
(Gibco. Grand Island, NY). Routine subcultures for A549 pneumocytes (passage 



















































528 ROTHMAN ET AL. 
incubation with 0.05% trypsin 0.02% ethylene diaminetetraacetic acid in calcium- 
magnesium free Hank's Balanced Salt Solution (Gibco, Grand Island, NY)  for 5-9 
minutes at 37OC. Cell cultures were incubated at 37OC in a humidified incubator 
with 5% C02  in air. 
Cell Culture Conditions for Sample Collection 
The A549 and WI-38 cell lines were grown in 75cm2 tissue culture flasks 
(Falcon, Oxnard, CA) in the appropriate complete media described above. 
Confluent WI-38 fibroblast cultures (1  x lo7 cells/flask) or confluent A549 
pneumocyte cultures (1 x 107 cells/flask) were used for all studies. Complement 
production experiments were begun by rinsing the confluent cell cultures 3 times 
with 10 ml sterile saline, followed by the addition of 10 ml of serum free or 15% 
FBS supplemented media with or without silica particles. These flasks were then 
incubated at 37OC in a humidified incubator with 5% C02  in air for 11 days. On 
day 1, 3, 5 ,  7 and 9, a 5 ml sample of medium from each cell culture flask was 
collected and replaced with 5 ml of the appropriate fresh medium. On the last day 
of culture (i.e. day 1 l), the total cell culture supernatant was obtained. All culture 
supernatant samples were centrifuged at 400 xg for 10 minutes to remove cellular 
debri then divided into 1 ml aliquots and stored at - 70OC. 
Cell Culture with Silica Particles 
Experiments examining the effects of silica particles on complement 
production by lung cells were initiated by adding a non-lethal dose of silica particles 
(1  mg/107 cells/flask) to confluent cell cultures. Silica particles were purchased 
from Sigma (Sigma Chemical Co., St. Louis, MO), and the particle size 
distribution was 0.5 to 10 microns with approximately 80% between 1 to 5 
microns. Silica particles were cleaned by boiling a 3% (w/v) slurry in IN HCl to 
remove contaminates such as Fe2O3, according to Dauber et a1 ( l l ) ,  then 



















































SILICA COMPLEMENT SUPPRESSION 529 
Antiserum 
The IgG fraction of goat anti-human C3 was purchased from Cappel 
Laboratories (Malvern, PA). Rabbit anti-human C5 antibody was prepared by 
immunizing rabbits subcutaneously with 250 pg purified human C5 (Calbiochem 
Biochemicals, San Diego, CA) in Freund's complete adjuvant (Difco Laboratories, 
Detroit, MI) (12). Serum was isolated from rabbit blood and tested for anti-human 
C5 antibody titer by double immunodiffusion analysis. Both normal human serum 
and C5 deficient human serum ( 13) were used to validate the specificity of the anti- 
human C5 antiserum. Rabbit anti-human C5 IgG was purified using a Protein A 
Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ), and assayed for purity 
by immunoelectrophoresis against purfied C5, normal human serum, or C5 
deficient human serum. Alkaline phosphatase conjugated to antiserum or antigen 
was prepared by the method of Voller et a1 (14). The enzyme preparation used was 
alkaline phosphatase, Sigma type VII-S (Sigma Chemical Co., St. Louis, MO) of 
specific activity lo00 units/mg. 
ELISA for Human C3 Antigen 
The immunoassay to quantitate human C3 antigen was performed in 96 
well flat bottom microtiter plates (Flow Laboratories, McLean, VA) using a 
competitive enzyme-linked immunospecific assay (ELISA) technique (9,15). The 
lower limit of detection for this ELISA was 50 ng C3/ml. Because the A549 
pneumocyte and WI-38 fibroblast cells were grown in media containing 15% FBS, 
the cross reactivity of the FBS was tested in this ELISA and was found to have no 
detectable cross reactivity. 
ELISA for Human C5 Antigen 
The immunoassay to quantitate C5 antigen was performed in 96 well flat 
bottom microtiter plates (Flow Laboratories, McLean, VA) using a competitive 



















































530 ROTHMAN ET AL. 
C5/ml. Because the A549 pneumocyte and WI-38 fibroblast cells were grown in 
media containing 15% FBS, the cross reactivity of the FBS in this ELISA was 
tested and no significant cross reactivity was found. 
Functional Assav for Human C5 
A hemolytic assay to quantitate functional C5 (C5 H50) was performed 
using antibody-coated sheep erythrocytes in veronal buffered saline with 0.1 % 
gelatin, 0.1 5mMCa++, and 1 .OmM mg ++. Generally, 250 pl of purified C5 
(Calbiochem Biochemicals, San Diego, CA) or test sample was added to 250 p1 of 
a 4.0% solution of C5 deficient serum (14). Next, 125 yl of antibody-coated sheep 
erythrocytes (3.33 x 107 cells/ml) was added to the mixture, followed by a 60 
minute incubation at 37OC. Following incubation, 1.0 ml isotonic saline was added 
and the samples were centrifuged at 450 x g for 6 minutes. Hemolysis was 
determined by evaluation of the resulting supernatants at the optical density of 412 
nm. Results were calculated by comparing the dilution at which 50% red blood cell 
lysis occurred in relation to the highly purfied C5 which was used as the standard in 
each assay. The 50% lysis point for this assay was approximately 1-5 ng C5/ml, 
and no cross reactivity between human C5 and FBS was detected using this 
functional assay. 
Silica and A549 Pneumocvte Culture Suuernatants 
To eliminate the possibility that depressed levels of antigenic C3 seen in the 
experiments described in the Results Section were simply a result of non-specific 
sticking of C3 molecules to silica particles, studies were done to determine the 
direct effect of silica on C 3  levels in culture supernatants obtained from A549 
pneumocytes. For these studies 1 mg of silica was incubated with 10 m l s  of A549 
pneumocyte culture supernatant for 30 minutes and the resulting antigenic C3 levels 
were determined by ELISA for C3 antigen. These studies demonstrated that 
antigenic C3 levels in silica treated and nonsilica treated culture supernatants were 



















































SILICA COMPLEMENT SUPPRESSION 53 1 
Protein Svnthesis bv A549 Pneumocytes 
To evaluate total protein synthesis, incorporation of radioactive amino acids 
into proteins synthesized by AS49 pneumocytes was utilized. For these studies the 
cells were grown to confluence in 48 well plates and maintained in serum free, or 
serum containing media methionine free F12 Ham's medium for 3 days in the 
presence of 50 pCi/ml L-[35 S] Methionine (1120 pCi/mmol, New England 
Nuclear, Boston, MA). At selected times in culture, after exposure to silica 
particles, cell supernatants were collected, centrifuged 400 xg for 10 minutes, 
aliquoted and stored at -70OC. These culture supernatants were utilized for analysis 
of total protein synthesis using TCA precipitation, i.e., equal volumes of 3sS- 
methionine labelled cell culture supernatant and 10% TCA, and 1% albumin as 
carrier protein, were incubated at 4°C for 30 minutes and then centrifuged at 400 xg 
for 20 minutes to precipitate 3%-methionine incorporated proteins. These same 
35s-methionine labelled A549 pneumocyte culture supernatants were examined for 
qualitative differences in total protein synthesis and secretion after exposure to silica 
particles by 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) as described by Laemmli (16). After electrophoresis the SDS-PAGE gels 
were fixed, vacuum dried, and radiolabelled proteins were visualized by 
autoradiography . 
Protein Assav 
A549 pneumocyte and WI-38 fibroblast serum free culture supernatants 
were analyzed for total protein content using a microprotein assay with a sensitivity 
range of 1 to 10 pg proteid0.1 ml as described by Bradford (17). 
Cell Viability 
Cell viability was examined by uptake of vital dye Erythrocin B (J.T. Baker 
Chemical Co., Phillipsburg, NJ) or Trypan Blue (Gibco Laboratories, Grand 
Island, NY) and visualited by light microscopy. In addition, lactate dehydrogenase 



















































532 ROTHMAN ET AL. 
or cell integrity (18). All LDH data was expressed as the percent of total LDH, 
where total LDH equaled the LDH released into the supernatant from 1 x 107 A549 
pneumocytes after exposure to Triton X-100. The percent LDH was calculated 
using the following equation: 
x 100 LDH content in experimental culture supernatant Total LDH % LDH = 
Momhologic Evaluation of Silica Effects on A549 Pneumocvtes 
Light MicroscoDy 
Interactions of silica particles with adherent (cultured) and nonadherent 
(suspension) A549 pneumocytes were evaluated by light microscopy. A549 
pneumocytes were cultured as described above for 5 days in the presence or 
absence of silica particles (1 mg/107 cells/flask). On day 5 adherent A549 
pneumocytes were removed from the tissue culture flasks by trypsinization, then 
washed 3x and resuspended in F12 Ham's medium. Wet mounts were made of 
A549 cells that had been cultured in the presence or absence of silica particles and 
evaluated by light microscopy. To eliminate the possibility that interactions of silica 
particles and adherent A549 pneumocytes were artifacts of sample preparation for 
microscopy, adherent A549 pneumocytes cultured for 5 days in the absence of 
silica particles were trypsinized, washed, and resuspended in F12 Ham's medium 
containing silica particles ( 1  mg/107 cells/lO ml). These nonadherent A549 
pneumocyte suspensions were incubated at 370 C for 30 minutes, then wet mounts 
were made and evaluated by the light microscopy. 
Electron Microscopy 
To evaluate the ultrastructural effects of silica on A549 pneumocytes, 
individual A549 cell cultures were drained of culture fluid and rinsed quickly with 
0.2M cacodylate buffer. The plate was flooded with 4% cacodylate buffered 



















































SILICA COMPLEMENT SUPPRESSION 533 
post-fixed with 2% osmium tetroxide for 30 minutes. The plates were rinsed with 
buffer and the cells scraped with a rubber policeman. The cells were collected in 
1.5 ml centrifuge tubes and centrifuged in 3 Beckman Microfuge B. The resulting 
pellet was dehydrated through a graded series of alcohol, propylene oxide, and 
embedded in an Epon-Araldite mixture. One micron thick sections were cut and 
stained with toluidine blue and several blocks were selected for thin sectioning (60 
mp). Thin sections were stained with uranyl acetate and lead citrate. Electron 
micrographs were taken on a Philips EM 300. 
Data Analysis 
Quantitation of absolute comulement component levels in individual cell 
culture supernatants were determined by direct comparison to the standard curves of 
known C3 and C5 antigen in the appropriate ELISA system and the final data was 
expressed as ng/ml. 
Quantitation of the total accumulated complement component levels in each 
culture supernatant were determined by using the equation below and the final data 
was expressed as ng/ml: 
L 
(j= 1) 
n = Days in culture, i.e. day 1, 3, 5 ,  7, 9 or 11. 
Xn = Absolute complement protein detected in a culture supernatant 
obtained on day n. 
Total accumulated complement protein produced by cells in culture 
from day 0 to day n. 
Yn = 
All data is expressed as the mean * the standard error of the mean (SEM), 



















































534 ROTHMAN ET AL. 
test (19). Stimulation index was calculated using the following general equation: 
Experimental value 
= Control value 
SIR = stimulation index for radioactive amino acid incorporation, 
s1c3 = stimulation index for antigenic C3, 
SICS = stimulation index for antigenic C5, and 
SIc5f = stimulation index for functional C5. 
RESULTS 
Effect of Fetal Bovine Serum on Complement Component Production by A549 
Pneumocvtes 
To begin our studies on complement component production by type I1 
pneumocytes we first determined the effects of different lots of fetal bovine serum 
(FBS) on C3 and C5 production by A549 pneumocytes in vitro. Initially, we 
cultured A549 pneumocytes in two different lots of FBS for 11 days and analyzed 
culture supernatants obtained on days 1, 3, 5,  7, 9 and 11 for antigenic C3 and C5 
levels by ELISA. Lot No. 2 of FBS stimulated a significantly greater rate of 
antigenic C3 production when compared to the effect of Lot No. 1, i.e. 335 ng 
C3/m1/24 hr versus 135 ng C3 m1/24 hr. Matched control cultures of A549 
pneumocytes cultured in serum free medium produced antigenic C3 at similar rates 
(62 ng C3/m1/24/hr [Lot No. 1 studies] versus 70 ng C3/m1/24 hr [Lot No. 2 
studies]). Additional studies with a third lot of FBS revealed similar effects on C3 
production by A549 cells as described for Lot No. 2 (data not shown). Similar 
FBS effects were seen when these same A549 pneumocyte culture supernatants 
were analyzed for C5 production, i.e., Lot No. 2 stimulated antigenic C5 
production at a rate of 320 ng C5/mY24 hr in comparison to the rate of 245 ng 
C5/m1/24 hr determined for Lot No. 1. Once again control cultures of A549 
pneumocytes cultured in serum free medium produced antigenic C5 at similar rates 
(148 ng CYmY24 hr versus 153 ng C5/mY24 hr). It is important to note, although 
there were variations in the absolute amount of C3 and C5 produced by A549 
pneumocytes cultured in different lots of FBS, the absolute amounts of C3 and C5 



















































SILICA COMPLEMENT SUPPRESSION 535 
consistent from experiment to experiment. Additionally, when experimental results 
were expressed as a stimulation index the modulation of complement component 
production in control cultures as well as those exposed to silica particles was 
constant, with less than 10% variation within any experimental condition, 
regardless of the lot of FBS used (see below). Additionally, baseline C3 and C5 
production by the A549 cells in serum free medium was similar in all the studies. 
Toxicitv of Silica Particles on A549 Pneumocvtes 
T o  begin our studies on silica induced modulation of complement 
component production by A549 pneumocytes, we examined the effects of silica on 
the viability of A549 cells in vitro by culturing these cells in the presence or absence 
of silica or FBS. Morphologically, A549 pneumocytes cultured in the presence of 
fetal bovine serum (FBS) with or without silica particles (1 mg/107 cellsjflask) 
remained a tightly packed epithelial cell monolayer. A549 cells cultured in the 
absence of FBS became spindle shaped and irregular (Figure IA), and these 
effects, including cellular retraction, were more enhanced in the presence of silica 
particles (Figure 1 B). Although the changes in A549 pneumocyte morphology 
detected in serum free cultures may likely be a result of subtle cell injury due to the 
lack of FBS as well as silica exposure, the dose of silica particles (1 mg/lO7 
cells/flask) used was not lethal, as A549 pneumocytes remained intact and attached 
to the tissue culture plastic substratum and excluded vital dyes. In addition, lactate 
dehydrogenase (LDH) levels in A549 cell culture supernatants were also measured, 
as an indicator of cell viability (18). The results of these studies demonstrated that 
A549 pneumocytes cultured in serum free medium with 1 mg silica particles/l07 
cells for 7 days showed no significant release of total LDH (i.e., 1.0%) when 
compared to A549 pneumocytes cultured in serum free medium alone (1.3%). 
Increasing the silica concentration to 10 mg silica particles/l07 cells had significant 
toxic effects on A549 cells as reflected by a 70% increase in total LDH release, 
above that detected in non silica exposed cultures. 
A549 pneumocyte integrity during exposure to silica particles was also 
assessed by both light and electron microscopy (Figure 2). Interestingly, silica 
particles were consistently associated with the cells in culture suggesting silica 



















































536 ROTHMAN ET AL. 
Figure 1: 
particles and A549 pneumocytes. 




Phase contrast micrographs of A549 pneumocytes after 5 days in culture 
in serum free medium, in the absence of silica particles (Figure 1A) or in 



















































SILICA COMPLEMENT SUPPRESSION 537 
A 
Figure 2. Light and electron microscopic evaluation of 
silica particle interaction with A549 pneumocytes. 
Interactions of silica particles with adherent (cultured) and nonadherent 
(suspension) A549 pneumocytes were evaluated by light microscopy. 
Adherent A549 pneumocytes cultured i n  the presence of silica ( 1  
mg/ 10' cells) displayed normal cell morphology and consistent 
internalization of numerous silica particles (See arrow in Panel B) when 
compared to A549 cells cultured in the absence of silica (Panel A) or 
suspension cultures of A549 pneumocytes exposed to silica (See arrow 
in Panel C). Electron microscopic evaluation of A549 pneumocytes 
cultured in the presence of silica demonstrated that although the A549 
cells internalized silica particles (See arrow in Panel E), there was no 
evidence of cellular toxicity, nor any major ultrastructural changes (e.g., 
normal lamellar bodies and cell surface microvilli) when compared to 



















































538 ROTHMAN ET AL. 
preparations of A549 pneumocytes after exposure to silica particles (1 mg/107 
cells/flask) for 5 days demonstrated that A549 cells internalized multiple silica 
particles and remained healthy (Figure 2, Panel B), and the interactions between 
silica particles and A549 pneumocytes were specific and not an artifact of sample 
preparation for microscopy (Figure 2, Panel C), since exposure of suspensions of 
A549 cells with silica for short time periods did not result in internalization of the 
silica (Figure 2). Our electron microscopy studies also showed A549 pneumocytes 
cultures exposed to silica particles phagocytized and internalized many silica 
particles per cell during culture in vitro. These in vift-5 observations are consistent 
with previous literature citations that have described type I1 pneumocytes in situ to 
have phagocytic capabilities (20-23). The non-toxic effects of the 1 mg dose of 
silica was supported by electron microscopic evaluation, i.e., A549 pneumocytes 
cultured in the presence of silica particles (1 mg/107 cells/flask) for 5 days appeared 
to be in excellent morphological condition, that is displayed normal cytoplasmic 
organelles, including numerous cytoplasmic multilamellar bodies, lipid filled 
vacuoles and cell surface microvilli (Figure 2, Panel E). Evidence of cellular 
dysfunction involving nuclear disorganization, cytoplasmic vacuolization or loss 
and disorganization of lamellar bodies was not detected. 
Silica and C3 Production bv A549 Pneumocvtes 
To begin our studies on the effects of silica on C3 production by A549 
pneumocytes we initially analyzed culture supernatants obtained on days 1, 3, 5, 7, 
9 and 11 post silica exposure for antigenic C3 levels. As shown in Figure 3, A549 
pneumocytes cultured in serum free medium plus a non-lethal dose of silica 
produced only slightly greater total accumulated antigenic C3 levels in comparison 
to A549 cells cultured in serum free medium without silica particles. Analysis of 
the data from a representative experiment (Figure 3) demonstrated that generally 
after 3 days in culture, A549 pneumocytes cultured in serum free medium produced 
C3 at a rate of 78.8k-29.4 ng C3/m1/24 hr (mean k SEM), which is similar to the 
rate of 88.5 * 41.5 ng C3/ml/24 hr determined for A549 cells cultured in serum free 
medium plus silica particles. In contrast, A549 pneumocytes maintained in 
medium containing FBS and silica particles produced significantly lower absolute 
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Figure 3. Effect of sillca on C3 @ d o n  by A549 pneumocyten 
Figure 3 demonstrates the klnetlcs of C3 productlon by A549 pneumocytes 
under various experimental conditions. The open bars represent absolute 
antlgenlc C3 levels (ng/ml) detected in culture supernatants obta.hed from 
A549 pneumocyte cultures maintained in medium supplemented with or 
without 15% FBS for 11 days. The hatched bars represent absolute antgenic 
C3 levels (ng/ml) in supernatants obtained from A549 pneumocyte cultures 
malntained ln medium supplemented with or  without 15% FBS. and  1 mg 
sillca particles for 11 days. The h e  graphs represent the total accumulated 
antigenic C 3  (ng/ml) produced by A549 pneumocytes under the condltlons 
descnbed above. 
during I 1  days in culture, in  comparison to A549 cells cultured without silica 
particles. Analysis of the data in Figure 3 showed that after 3 days in culture, A549 
pneumocytes cultured in FBS containing medium plus silica generally produced C3 
at a rate of 42.02 4.7 ng C3/m1/24 hr which is significantly slower than the rate 
calculated for A549 cells cultured in FBS containing medium alone, 94.& 23.5 ng 
C3/m1/24 hr (p  < 0.01). To eliminate the possibility that depressed levels of 



















































540 ROTHMAN ET AL. 
non-specific sticking of C3 molecules to silica particles, we demonstrated that 
neither C3 or C5 would adhere to silica (see material and methods section). When 
data from 5 independent experiments were analyzed for the stimulation index for C3 
production (Figure 4) it can be seen that: 1) A549 pneumocytes cultured in serum 
free medium plus silica particles had a maximum SIc3 = 1.12 * 0.06 indicating 
negligible effects on C3 production, and 2) A549 cells cultured in FBS containing 
medium plus silica particles showed significant suppression of C3 production, e.g., 
by day 11 the SIc3 = 0.58 * 0.02 (Figure 4). 
Silica and C5 Production bv A549 Pneumocytes 
Given the importance of C3 and C5 during an inflammatory reaction and the 
observation that silica particles could suppress A549 pneumocyte production of C3, 
we next investigated the ability of silica to modulate C5 production. For these 
studies, these same A549 pneumocyte culture supernatants were analyzed for 
effects of silica particles on antigenic C5 levels using an ELISA technique. Since 
the ELISA only measured antigenic C5 levels, and could not distinguish functional 
C5 proteins from non-functional C5 proteins, we also examined the effects of silica 
particles on functional C5 protein levels using a hemolytic titration assay. In 
general, A549 cells cultured in serum free medium plus a non-lethal dose of silica 
(1 mg/lO7 cells/flask) produced similar levels of absolute and total accumulated 
antigenic C5 when compared to A549 cells cultured in serum free medium without 
silica particles (Figure 5). Specifically, A549 pneumocytes cultured in serum free 
conditions produced antigenic C5 at a rate almost identical to that determined for 
A549 cells exposed to silica particles, i.e., 148.5 * 11.8 ng C5/m1/24 hr versus 
148.3 * 37.3 ng C5/mV24 hr. Analysis of functional C5 levels in these same A549 
pneumocyte culture supernatants demonstrated that exposure to silica also had no 
dramatic effect on functional C5 production (Figure 6) and that the rate of functional 
C5 production was 122.6 * 11.7 ng C5/m1/24 hr for A549 cells in serum free 
medium, and 97.8 10.1 ng C5/ml/24 hr for A549 cells exposed to silica particles. 
In contrast, A549 pneumocytes cultured in medium supplemented with FBS and 
silica particles produced significantly lower levels of both absolute and total 
accumulated antigenic C5 and functional C5 when compared to A549 cells cultured 
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DAYS IN CULTURE 
Figure 4. Efkct ofsilica on C3 and C5 production byA549 pneumocytes. 
The open symbols represent the mean stimulation index (Sr) calculated for 
culture supernatants obtained from A549 pneumocyte cultures maintained 
in medium without 15% FBS plus 1 mg slllca particles for 11 days. The h e  
graphs with the open symbols represent SI for antfgenic C3 (n=7). antigenic 
C5 (n=71. and functional C5 ln=?1 . The cl& symbols represent the mean SI 
calculated for culture supernatants obtained from A549 pneumocyte cultures 
maintained In medlum with 1 5 O h  FBS plus 1 mg sfflca particles for 11 days. 
The h e  graphs with the closed symbols represent SI for antgenic C3 (n=5). 
antigenic C5 (n=4). and functional C5 (n=4). The SEM was less than 10% for 
all data presented. 
showed that after 5 days in culture, A549 pneumocytes cultured in FBS containing 
medium plus silica produced antigenic C5 at a rate of 129.3 * 11.3 ng C 5 / d 2 4  hr, 
which is significantly slower that the 273. 0 * 70.2 ng C5/m1/24 hr determined for 
A549 cells cultured without silica particles (p <0.02). As shown in Figure 6, 
fuctional C5 production was also significantly suppressed when A549 cells were 
exposed to silica particles for 11 days, i.e., the rate of functional C5 production 
was 105.3 * 30.0 ng C5/m1/24 hr versus 212.8 * 35.4 ng C5/m1/24 hr (p <0.05). 
These patterns of modulation by a non-lethal dose of silica on C5 production by 
A549 pneumocytes were documented in several independent experiments as shown 
in Figure 4. Specifically, A549 pneumocytes cultured in serum free medium plus 
silica particles had a stimulation index for antigenic C5 production (SICS: mean * 
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The open bars represent absolute antigenic C5 lwels (ng/ml) detected in 
culture supernatants obtained from A549 pneumocyte cultures maintained 
in medlum supplemented with or without 15% FBS for 11 days. 'Ihe hatched 
bars repnsent absolute antfgenic C5 levels (ng/ml) in supernatants obtained 
from A549 pneumocyte cultures maintained ln medtum supplemented with 
or wlthout 15% FBS. and 1 mg sfflca particles for 11 days. ?he line graphs 
represent the total accumulated antigenic C5 (ng/ml) produced by A549 
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Mgure 6. Effect afsillca on funct3onal C5 production by-9 pneumocytes. 
The open bars represent absolute functional C5 levels (ng/ml) detected in 
culture supernatants obtained from A549 pneumq-te  cultures malntalned 
in medium supplemented with or without 15% FBS for 11 days. The hatched 
bars represent absolute functional C5 levels Ing/ml) in supernatants 
obtained from A549 pneumocyte cultures maintained in medium 
supplemented with or without 15% FBS. and 1 mg sillca partlcles for 11 
days. The h e  graphs represent the total accumulated functional C5 (ng/ml) 
produced by A549 pneumocytes under the conditions described above. 
production (SIc5f: mean * SEM) of SIc5f = 0.94 2 0.02 (n=7) during 11 days in 
culture. In addition, analysis of culture supernatants from at least 4 independent 
experiments of A549 pneumocytes cultured in medium supplemented with FBS and 
silica demonstrated suppression of C5 production by day 3 in culture, with 
maximum suppression detected on day 11 for both antigenic C5 and functional C5, 
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1 2 3  4 
Figure 7. Effect of silica particles on total protein 
synthesis and secretion by A549 pneumocytes. 
Figure 7 is an autoradiograph of a SDS-PAGE (7.5%) of culture 
supernatants obtained from A549 pneumocyte cultures that were 
metabolically labeled for 3 days with 35S-methionine. Lane 1, serum 
free A549 cell culture supernatant; Lane 2, serum free A549 cell culture 
supernatant with silica particles (20.8 pg silicd48 well); Lane 3, 15% 
FBS A549 cell culture supernatant; and Lane 4, 15% FBS A549 cell 
culture supernatant with silica particles (20.8 pg silicd48 well). 
Silica and Protein Synthesis by A549 Pneumocytes 
Since silica induced suppression of complement component production by 
A549 pneumocytes may have been a result of non-specific suppression of total 
protein synthesis (a response due to cell injury) or specific suppression of C3 and 
C5 production (i.e., specific effects on gene expression and/or secretion) we 



















































SILICA COMPLEMENT SUPPRESSION 545 
cultured in methionine free medium supplemented with 3%-methionine and the 
effects of silica exposure on total protein synthesis were quantitated as percent TCA 
precipitable radioactivity, i.e., radiolabelled proteins. Data from these experiments 
demonstrated that there was no significant difference in 35s-methionine 
incorporation into total protein, when A549 cells were cultured with or without a 
non-lethal dose of silica. The stimulation index for radioactive amino acid 
incorporation (SIR: Silicdcontrol mean SEM) demonstrated that silica had no 
effect on total protein synthesis by A549 pneumocytes, i.e.,SIR = 1.05 * 0.02 for 
serum free cultures (n=2), and a SIR = 1.20 0.01 for FBS cultures (n=2). 
Although silica particles did not effect total protein synthesis by A549 pneumocytes 
it may have altered the synthesis of specific proteins thus we analyzed 35s-  
methionine labelled culture supernatants by 7.5% SDS-PAGE followed by 
autoradiography to examine the qualitative differences in protein synthesis. Figure 
7 shows an autoradiograph of a representative PAGE which demonstrates that there 
are no apparent qualitative differences in the array of proteins synthesized and 
secreted by A549 pneumocytes in the presence or absence of silica particles. Not 
unexpectedly, culturing A549 pneumocytes with or without silica in the presence 
of cycloheximide ( 1  mgml) caused inhibition of not only C3 and C5 production, but 
total protein synthesis which was reversed by the removal of the cycloheximide 
(data not shown). In summary, these data eliminate the possibility that silica 
particle modulation of C3 and C5 production is a result of generalized effects of 
silica on total protein synthesis by A549 pneumocytes, and suggest that the 
suppression of C3 and C5 production during exposure to silica particles may be a 
reflection of specific effects on either gene expression (pre-translational level) or 
secretion (post-translational level) of the third and fifth complement components. 
Effect of Silica on Complement Component Production by WI-38 Lung Fibroblasts 
To determine whether silica particles could modulate complement 
component production by other isolated human lung cells, we next evaluated the 
effects of a non-lethal dose (i.e., 1 mg/lO7 celldflask) of silica on WI-38 fibroblast 
production of C3 and C5. Confluent cultures of WI-38 fibroblasts were 
maintained for 11 days in the presence or absence of FBS, with or without silica 



















































546 ROTHMAN ET AL. 
or FBS containing medium formed monolayers of numerous swirls of elongated 
cells oriented in parallel to each other. The addition of a non-lethal dose of silica (1 
mg/flask) had no effect on fibroblast cell morphology. At selected times during the 
11 day culture period, culture supernatants were obtained, and analyzed for 
antigenic C3 and antigenic C5 levels. The results showed that the presence of silica 
particles in WI-38 fibroblast cultures, maintained in serum free medium, did not 
modulate antigenic C3 or antigenic C5 levels when compared to WI-38 fibroblasts 
maintained in the absence of silica, i.e., the S Ic3  = 1.09 * 0.07 (n=7) and the 
SICS = 1.00 0.03 (n=12). Similar data was obtained for W1-38 fibroblasts 
cultured in medium supplemented with FBS. Therefore, it appears that not all 
human lung cells are susceptible to the modulating effects of a non-lethal dose of 
silica particles on their capability to produce complement components in v i m .  
DISCUSSION 
Although previous studies have focused on various aspects of complement 
component production by inflammatory cells (i.e., monocyte/macrophage), very 
little is known about the capability of normal or injured tissue cells to produce 
complement components in vivo or in vitro. Thus to fill this important gap area, 
our laboratory has recently studied complement production by lung type I1 
pneumocytes (A549) and lung fibroblasts (WI-38) as prototypes of tissue specific 
cells. Using %-methionine incorporation and immunoprecipitation of specific 
complement components, these investigations have demonstrated the capability of 
type I1 pneumocytes to synthesize and secrete numerous complement components 
and regulatory proteins including Clr, Cls, C4, C3, C5, C6, C7, C8, C9, Factor B, 
Factor H, Factor I and Cls inactivator in v i m  (10). In comparison, lung fibroblasts 
were shown to synthesize Cls, C4, C3, C5, C6, C8 and C9. In summary, these 
studies revealed four important finding: 1) in vitro, A549 pneumocytes and WI-38 
fibroblasts can synthesize and secrete a wide variety of early and terminal 
complement components, 2) lung cells synthesize and secrete a number of 
complement components (e.g., C6, C7, C8, C9 and Cls inactivator), not described 
to be produced by the monocyte/macrophage, 3) type I1 pneumocytes produce 
significantly greater amounts of C3 (20 fold increase), as quantitated by an enzyme- 



















































SILICA COMPLEMENT SUPPRESSION 547 
and 4) using 3%-methionine incorporation and immunoprecipitation techniques, 
the C3 and C5 produced by the type I1 pneumocytes is physiochemically identical to 
serum C3 and C5. These data clearly indicate that on a per cell basis, the type I1 
pneumocyte likely represents a major source of local complement component 
production within the lung. This data assumes additional importance in light of the 
fact that within the normal lung alveoli, tissue epithelial cells are far more numerous 
than alveolar macrophages, and that the number of type I1 pneumocytes markedly 
increases as a result of lung injury such as silica inhalation (1 1,2529).  Clearly, 
agents or factors which enhance or suppress production of complement components 
by these tissue cells would likely have a significant impact on the resolution of lung 
diseases. 
Silicosis has long been recognized as a major health hazard associated with 
a wide variety of occupations (30). Generally, silicosis involves the inhalation of 
silica particles penetrating deep into lung tissue, which is followed by the uptake of 
the particles by lung cells including macrophages and epithelial cells (30,31). Once 
ingested, silica eventually leads to cell destruction, increased accumulation of cells, 
and ultimately, production of collagen and hyaline membrane formation within the 
lung (30). In addition to the pathologic effects of silica on the lung, a variety of 
studies have demonstrated that silica suppresses immune function. For example, 
silica is known to decrease antibody production in vivo as well as macrophage and 
lymphocyte function in v i m  (32,33). Additional studies have demonstrated the 
presence of complement-dependent chemotactic factors in the lavage fluid of 
patients with silicosis, thus a role for the complement system in the etiology of 
silicosis has been suggested (3 1). Since silica has been directly demonstrated to 
induce pulmonary inflammation and induce immunosuppression (30-34), we 
examined the effects of silica on complement production by type I1 pneumocytes 
and lung fibroblasts. In our present studies using sensitive ELISAs, we 
demonstrated that silica particles had the capability to suppress both C3 and C5 
production by type I1 pneumocytes by 40-50 percent without alteration of total 
protein synthesis as demonstrated by 35S-methionine incorporation studies. These 
data suggest that suppression of both C3 and C5 production was a specific 
response rather than a generalized response of the type 11 pneumocyte to silica. 
Furthermore, the C3 and C5 levels produced by A549 pneumocytes cultured in the 
presence of FBS and absence of silica particles were significantly higher than the 



















































548 ROTHMAN ET AL. 
silica, or 2) cells cultured in serum free conditions in the presence or absence of 
silica. These results suggest that complement production by A549 pneumocytes is 
responsive to not only silica, but also to culture conditions, i.e.,a nutrient-deprived 
environment (such as in serum free culture conditions), and factors within serum 
(cytokines, growth factors, hormones, etc.). Interestingly, silica had no effect on 
C3 or C5 production by WI-38 fibroblasts. Thus, these studies not only 
demonstrate the capability of silica, which has been implicated in pulmonary 
inflammation, to regulate complement production by type I1 pneumocytes, but that 
this regulation may be unique to the type I1 cell since it does not occur in the lung 
fibroblast. These observations suggest that during pulmonary disease such as 
silicosis, resident lung cells (such as type I1 pneumocytes) may have a direct impact 
on pulmonary host defense and inflammation by directly altering tissue levels of 
important complement components such as C3 and C5. 
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